• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase.

作者信息

Caminati Marco, Crisafulli Ernesto, Lunardi Claudio, Micheletto Claudio, Festi Giuliana, Maule Matteo, Giollo Alessandro, Orsolini Giovanni, Senna Gianenrico

机构信息

Department of Medicine, University of Verona and Verona University Hospital, Verona, Italy.

Department of Medicine, Respiratory Medicine Unit and Section of Internal Medicine, University of Verona and Verona University Hospital, Verona, Italy.

出版信息

J Allergy Clin Immunol Pract. 2021 Mar;9(3):1386-1388. doi: 10.1016/j.jaip.2020.09.025. Epub 2020 Oct 1.

DOI:10.1016/j.jaip.2020.09.025
PMID:33011303
Abstract
摘要

相似文献

1
Mepolizumab 100 mg in severe asthmatic patients with EGPA in remission phase.在处于缓解期的伴有嗜酸性肉芽肿性多血管炎（EGPA）的重度哮喘患者中使用100毫克美泊利单抗。
J Allergy Clin Immunol Pract. 2021 Mar;9(3):1386-1388. doi: 10.1016/j.jaip.2020.09.025. Epub 2020 Oct 1.
2
Eosinophilic granulomatosis with polyangiitis successfully treated with benralizumab.使用贝那利珠单抗成功治疗嗜酸性肉芽肿性多血管炎。
Ann Allergy Asthma Immunol. 2020 Aug;125(2):228-230. doi: 10.1016/j.anai.2020.05.002. Epub 2020 May 11.
3
Pharmacogenetic investigation of efficacy response to mepolizumab in eosinophilic granulomatosis with polyangiitis.药物遗传学研究美泊利珠单抗治疗嗜酸性肉芽肿性多血管炎的疗效反应。
Rheumatol Int. 2020 Aug;40(8):1301-1307. doi: 10.1007/s00296-020-04523-6. Epub 2020 Feb 3.
4
Optimal therapy and prospects for new medicines in eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome).嗜酸性肉芽肿性多血管炎（Churg-Strauss 综合征）的最佳治疗方法和新药前景。
Expert Rev Clin Immunol. 2016 Oct;12(10):1059-67. doi: 10.1080/1744666X.2016.1191352. Epub 2016 Jun 6.
5
Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.美泊利单抗用于治疗嗜酸性肉芽肿性多血管炎。
Drugs Today (Barc). 2018 Feb;54(2):93-101. doi: 10.1358/dot.2018.54.2.2788013.
6
Churg-Strauss syndrome.变应性肉芽肿性血管炎。
Autoimmun Rev. 2015 Apr;14(4):341-8. doi: 10.1016/j.autrev.2014.12.004. Epub 2014 Dec 11.
7
Eosinophilic pneumonia in an asthmatic patient treated with omalizumab therapy: forme-fruste of Churg-Strauss syndrome?接受奥马珠单抗治疗的哮喘患者发生嗜酸性粒细胞性肺炎：是变应性肉芽肿性血管炎（Churg-Strauss综合征）的顿挫型吗？
Allergy. 2009 Sep;64(9):1389-90. doi: 10.1111/j.1398-9995.2009.02061.x. Epub 2009 Apr 14.
8
Early add-on administration of mepolizumab and intravenous immunoglobulin effective in treating eosinophilic granulomatosis with polyangiitis.美泊利珠单抗和静脉注射免疫球蛋白早期联合给药对治疗嗜酸性肉芽肿性多血管炎有效。
J Dermatol. 2021 Apr;48(4):529-532. doi: 10.1111/1346-8138.15709. Epub 2020 Dec 10.
9
Eosinophilic Granulomatosis With Polyangiitis: Newer Therapies.嗜酸性肉芽肿伴多血管炎：新疗法。
Curr Rheumatol Rep. 2018 Apr 2;20(5):23. doi: 10.1007/s11926-018-0736-2.
10
Omalizumab: a novel steroid sparing agent in eosinophilic granulomatosis with polyangiitis?奥马珠单抗：一种用于嗜酸性肉芽肿性多血管炎的新型类固醇节省剂？
Clin Exp Rheumatol. 2013 Jan-Feb;31(1 Suppl 75):S91-2. Epub 2012 Oct 18.

引用本文的文献

1
Strategies for Tapering the Dosage of Biologics Targeting Type 2 Inflammation: A Systematic Review.降低靶向2型炎症生物制剂剂量的策略：一项系统评价
Curr Allergy Asthma Rep. 2025 Jul 28;25(1):32. doi: 10.1007/s11882-025-01214-9.
2
Impact of mepolizumab on the AAV-PRO questionnaire in eosinophilic granulomatosis with polyangiitis: data from a European multicentre study.美泊利单抗对嗜酸性肉芽肿性多血管炎患者AAV-PRO问卷的影响：一项欧洲多中心研究的数据
Rheumatology (Oxford). 2025 Sep 1;64(9):4937-4947. doi: 10.1093/rheumatology/keaf232.
3
Mepolizumab and benralizumab in patients with severe asthma and a history of eosinophilic granulomatosis with polyangiitis.
美泊利单抗和贝那利单抗用于治疗重度哮喘且有嗜酸性肉芽肿性多血管炎病史的患者。
Front Med (Lausanne). 2024 Mar 22;11:1341310. doi: 10.3389/fmed.2024.1341310. eCollection 2024.
4
Low-dose anti-IL 5 treatment in idiopathic hypereosinophilic syndrome: towards a precision medicine approach for remission maintenance.低剂量抗白细胞介素 5 治疗特发性嗜酸性粒细胞增多综合征：实现缓解维持的精准医学方法。
Orphanet J Rare Dis. 2023 Sep 26;18(1):302. doi: 10.1186/s13023-023-02918-9.
5
Effectiveness and safety of anti-IL-5/Rα biologics in eosinophilic granulomatosis with polyangiitis: a two-year multicenter observational study.抗白细胞介素-5/受体α 生物制剂治疗嗜酸性肉芽肿伴多血管炎的疗效和安全性：一项为期两年的多中心观察性研究。
Front Immunol. 2023 Jun 30;14:1204444. doi: 10.3389/fimmu.2023.1204444. eCollection 2023.
6
Characteristics of severe asthma patients on biologics: a real-life European registry study.接受生物制剂治疗的重度哮喘患者的特征：一项欧洲真实世界注册研究
ERJ Open Res. 2023 May 2;9(3). doi: 10.1183/23120541.00586-2022. eCollection 2023 Jul.
7
Roles of real-world evidence in severe asthma treatment: challenges and opportunities.真实世界证据在重度哮喘治疗中的作用：挑战与机遇。
ERJ Open Res. 2023 Apr 11;9(2). doi: 10.1183/23120541.00248-2022. eCollection 2023 Mar.
8
New Insights into Pathogenesis and Treatment of ANCA-Associated Vasculitis: Autoantibodies and Beyond.抗中性粒细胞胞浆抗体相关血管炎发病机制与治疗的新见解：自身抗体及其他方面
Antibodies (Basel). 2023 Mar 21;12(1):25. doi: 10.3390/antib12010025.
9
At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement.嗜酸性肉芽肿性多血管炎的核心：深入探讨心脏和血管受累情况
Curr Rheumatol Rep. 2022 Nov;24(11):337-351. doi: 10.1007/s11926-022-01087-1. Epub 2022 Oct 4.
10
Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study.美泊利珠单抗治疗嗜酸性肉芽肿性多血管炎：一项欧洲多中心观察性研究。
Arthritis Rheumatol. 2022 Feb;74(2):295-306. doi: 10.1002/art.41943. Epub 2021 Dec 30.